NIFTY  9,351.85  0.49%
  SENSEX  30,133.30  0.63%
 CURRENCY  Rs  64.28/$ 70.28/€, 82.54/£
  GOLD  28,734.00  -0.28%
  SILVER  40,200.00  -0.53%
  DAX  12,467.00  0.10%
  FTSE  7,275.64  0.15%
  CAC  5,277.88  0.15%
  HANG SENG  24,578.40  0.50%
  NIKKEI  19,289.40  1.10%
  Shanghai Composite  3,140.85  0.10%
  DOW JONES  20,996.10  1.12%
  NASDAQ  6,025.49  0.70%
  S&P 500  2,388.61  0.61%
LAKSHMI VILAS BANK : Q4 PAT At Rs 52.1 Cr Vs Rs 49 Cr, Up 6.3% YoY LAKSHMI VILAS BANK : Q4 Provisions At Rs 108 Cr Vs Rs 27.1 Cr YoY LAKSHMI VILAS BANK : Q4 Gross NPA At 2.67% Vs 2.78% QoQ LAKSHMI VILAS BANK : Q4 Net NPA At 1.76% Vs 1.82% QoQ LAKSHMI VILAS BANK : To Pay Rs 2.70/Share As Dividend

Aurobindo To Set Up Exclusive Hyd Plant

Video:

Play this video

March 6: Following Aurobindo Pharma's Rs.220 crore deal to acquire Actavis’ Western European operations, sources tell Bloomberg TV India that the company now plans to set up another drug facility in Hyderabad. The move has been strategically planned so that it can cut costs and also manufacture some of Actavis’ products domestically. The transfer of licenses is expected to be completed in six months. Priya Sheth shares a detailed report on the same.